Help page of CancerEnD and FAQ

This page visually guides the users of CancerEnD in making search agsinst CancerEnD database. For each module which is implemented in CancerEnD, here we have provided the figures and description on how to use that module.



Simple search


Simple search
This module allows extensive search against CancerEnD. User can select one or multiple desired fields for querying. User can click on each ID to get all the details about an entry.

Pic-1



Complex Search
This module provides the advanced search facility in CancerEnD database. User can perform search on any or all fields of CancerEnD database.

Complex Search is quite helpful when user has predefined query in mind. For instance, User come up with the following questions in mind and wants to SEARCH
Pic-1



Browse data


Browse data
This module allows users to browse data stored in CancerEnD database in different functional categories.


By cancer type
This facility provides the user with the statistical details corresponding to different cancer types.

Pic-1

Other useful features


Additional information
This facility provides the user with the statistical details corresponding to different cancer types.

Pic-1

Frequently Asked Questions (FAQs)


Q1. What information does CancerEnD provides?
CancerEnD (Cancer En- Enhancer D- Database) is a repository of enhancer element, built by taking data from TCGA and COSMIC. It provides information on enhancer associated copy number change, linkage to patient survival, somatic mutation, enhancer expression across cancer patient wise and enhancer associated genes.

Q2. What can CancerEnD do?
With CancerEnD you can:
- look for common and unique enhancer for among each cancer type present in database.
- browse for different functional categories of enhancer like cancer type, copy number change, somatic mutation and survival.

Q3. Can the data stored in CancerEnD is downloadable?
User can download the entire data stored in CancerEnD database in three format viz. plain text, xlsx and in CSV format.